Power for Cluster-Randomized Trials: Software, Web app, and Methods
整群随机试验的力量:软件、Web 应用程序和方法
基本信息
- 批准号:9897605
- 负责人:
- 金额:$ 27.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-15 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced Malignant NeoplasmBathingCluster randomized trialCodeCommunity HospitalsComparison armComplexComputer softwareEbola VaccinesEthicsExposure toGenerationsHospitalsIndividualIntensive Care UnitsKnowledgeMethodsMoralsNosocomial InfectionsPalliative CarePaperPatientsPersonsPhysiciansProphylactic treatmentProtocols documentationRandomizedResearchResearch DesignResearch PersonnelResistanceResourcesRiskSample SizeTextbooksTimeTrainingVariantanalytical methodbasecostdesignineffective therapiesmembermulti-arm trialopen sourcepathogenpreventscreeningsimulationstandard caretooltreatment grouptreatment risktreatment trialtrial designvaccine trialventilationwastingweb app
项目摘要
Summary
Cluster-randomized trials are an increasingly common trial design that has unique advantages for some
questions and is required for others. It has also spawned several related trial designs. Recent high-profile
studies using these designs include trials of Ebola vaccines and for preventing the spread of resistant
pathogens in hospitals. The key feature of cluster-randomized trials is that subjects are randomized in groups,
rather than as individuals, so that all members of a community, hospital, or practice receive the same
treatment.
All trials must have accurate power and sample size calculation for moral and ethical reasons. It is wrong to
randomize more persons than are needed for good power, as this exposes the excess persons to the risks of
randomization unnecessarily. It is also wrong to randomize fewer persons than create good power, as then all
are exposed to the risks of the study for naught—there is little hope of showing a benefit of any treatment-- and
a lack of study effect may be due to poor power rather than ineffective treatments. Though it is a lesser
concern, it is also unethical to have too small or large a sample size, as this wastes scarce resources such as
the investigators’ time and the funder’s dollars.
For some cluster-randomized trial designs, there exist analytic (closed-from) sample size formulae that rely on
assumptions that can be unrealistic. For other designs, only approximate formulae exist. In general, these
calculations can be found only in textbooks, scientific papers, and in software that is costly and can be difficult
to understand and apply. There are very limited options for the most accurate calculations, which are based
on simulations. Simulation-based power calculations can accommodate complex designs and realistic
scenarios that are only awkwardly possible in formulae.
We propose to generate a comprehensive free and open-source software suite to provide approximate,
analytic, and simulation-based power assessment. In addition, we will develop a web app for the code to allow
users who have less computing knowledge to make use of the software. Finally, we will make use of the
software to answer outstanding questions in the design of cluster-randomized trials.
总结
随机对照试验是一种越来越常见的试验设计,对某些人来说具有独特的优势。
问题,并要求其他人。它还催生了几个相关的试验设计。最近高调
使用这些设计的研究包括埃博拉疫苗的试验和预防耐药病毒的传播。
医院里的病原体整群随机试验的主要特点是受试者被随机分组,
而不是作为个人,以便社区,医院或实践的所有成员都能获得同样的服务。
治疗
出于道德和伦理原因,所有试验都必须有准确的把握度和样本量计算。是错误
随机化的人数超过了良好权力所需的人数,因为这会使多余的人面临以下风险:
不必要的随机化。这也是错误的随机少的人比创造良好的权力,因为然后所有
暴露在研究的风险中毫无意义-几乎没有希望显示任何治疗的益处-并且
缺乏研究效果可能是由于把握度差,而不是治疗无效。虽然这是一个较小的
关注,样本量太小或太大也是不道德的,因为这浪费了稀缺的资源,
调查人员的时间和出资人的钱
对于某些簇随机试验设计,存在依赖于以下内容的分析(封闭)样本量公式
假设可能是不现实的。对于其他设计,仅存在近似公式。总的来说这些
计算只能在教科书、科学论文和昂贵且困难的软件中找到
理解和应用。最准确的计算的选择非常有限,这些计算基于
在模拟上。基于仿真的功率计算可以适应复杂的设计,
只有在公式中才有可能的情况。
我们建议生成一个全面的免费和开源软件套件,
分析和基于模拟的功率评估。此外,我们将开发一个Web应用程序的代码,以允许
让电脑知识较少的用户使用该软件。最后,我们将利用
软件,以回答突出的问题,在设计的集群随机试验。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Type I error control for cluster randomized trials under varying small sample structures.
- DOI:10.1186/s12874-021-01236-7
- 发表时间:2021-04-03
- 期刊:
- 影响因子:4
- 作者:Nugent JR;Kleinman KP
- 通讯作者:Kleinman KP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kenneth P. Kleinman其他文献
Kenneth P. Kleinman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kenneth P. Kleinman', 18)}}的其他基金
Common and distinct early environmental influences on cardiometabolic and respiratory health: Mechanisms and methods
早期环境对心脏代谢和呼吸系统健康的常见和独特影响:机制和方法
- 批准号:
9355742 - 财政年份:2016
- 资助金额:
$ 27.94万 - 项目类别:
Common and distinct early environmental influences on cardiometabolic and respiratory health: Mechanisms and methods
早期环境对心脏代谢和呼吸系统健康的常见和独特影响:机制和方法
- 批准号:
10238793 - 财政年份:2016
- 资助金额:
$ 27.94万 - 项目类别:
Common and distinct early environmental influences on cardiometabolic and respiratory health: Mechanisms and methods
早期环境对心脏代谢和呼吸系统健康的常见和独特影响:机制和方法
- 批准号:
9262718 - 财政年份:2016
- 资助金额:
$ 27.94万 - 项目类别:
Common and distinct early environmental influences on cardiometabolic and respiratory health: Mechanisms and methods
早期环境对心脏代谢和呼吸系统健康的常见和独特影响:机制和方法
- 批准号:
10011924 - 财政年份:2016
- 资助金额:
$ 27.94万 - 项目类别:
Methods for evaluating bioterrorism surveillance tools
评估生物恐怖主义监视工具的方法
- 批准号:
6910501 - 财政年份:2005
- 资助金额:
$ 27.94万 - 项目类别:
Methods for evaluating bioterrorism surveillance tools
评估生物恐怖主义监视工具的方法
- 批准号:
7070062 - 财政年份:2005
- 资助金额:
$ 27.94万 - 项目类别: